Megan Y.

Megan Y. serves as the Chief Executive Officer and General Partner at Y Innovations, leading a group focused on strategic consulting, start-up incubation, and venture funding since August 2019. As Co-Founder and Chief Executive Officer of Y Innovations Studios, Megan Y. has established a venture studio that provides critical resources and support for innovative projects. Currently, Megan Y. is involved with several organizations as a strategic advisor, board member, and consultant, including ParcelBio and Immoon Therapeutics, the latter developing innovative treatments for non-Hodgkin lymphomas. Megan Y. has held various legal and strategic roles in biotech and law firms, including Deputy General Counsel at SQZ Biotechnologies and Head of Intellectual Property at Genevant Sciences. Educational credentials include degrees from the University of Oxford in International Law and institutions such as Georgetown University School of Medicine, The George Washington University Law School, and Questrom School of Business at Boston University.